PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: Possible implications for PARP-1 inhibitor therapy

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 861-869

  Domagala, Pawel ^a   Huzarski, Tomasz ^a   Lubinski, Jan ^a   Gugala, Karol ^b   Domagala, Wenancjusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Regional Oncology Hospital   (Poland)

Author keywords

Basal like; BRCA1; Breast cancer; PARP 1; Triple negative

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; ENZYME ANTIBODY; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL LIKE TUMOR; BRCA1 ASSOCIATED BREAST CARCINOMA; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TISSUE MICROARRAY; TRIPLE NEGATIVE TUMOR;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION; POLY(ADP-RIBOSE) POLYMERASES; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955738892     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1441-2     Document Type: Article

References (23)

1. V Schreiber F Dantzer JC Ame G de Murcia 2006 Poly(ADP-ribose): novel functions for an old molecule Nat Rev Mol Cell Biol 7 517 528 16829982 10.1038/nrm1963 1:CAS:528:DC%2BD28Xms1Ohsb4%3D (Pubitemid 44036457)
2. H Farmer N McCabe CJ Lord AN Tutt DA Johnson TB Richardson M Santarosa KJ Dillon I Hickson C Knights NM Martin SP Jackson GC Smith A Ashworth 2005 Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 917 921 15829967 10.1038/nature03445 1:CAS:528:DC%2BD2MXjtFOmsrc%3D (Pubitemid 40559006)
3. HE Bryant N Schultz HD Thomas KM Parker D Flower E Lopez S Kyle M Meuth NJ Curtin T Helleday 2005 Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 913 917 15829966 10.1038/nature03443 1:CAS:528:DC%2BD2MXjtFOmsrY%3D (Pubitemid 40559005)
4. B Evers R Drost E Schut M de Bruin E van der Burg PW Derksen H Holstege X Liu E van Drunen HB Beverloo GC Smith NM Martin A Lau MJ O'Connor J Jonkers 2008 Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin Clin Cancer Res 14 3916 3925 18559613 10.1158/1078-0432. CCR-07-4953 1:CAS:528:DC%2BD1cXntlWrtb8%3D
5. S Rottenberg J Jonkers 2008 Modeling therapy resistance in genetically engineered mouse cancer models Drug Resist Updat 11 51 60 18165147 10.1016/j.drup.2007.11.002 1:CAS:528:DC%2BD1cXlslWquro%3D
6. T Hay JR Matthews L Pietzka A Lau A Cranston AO Nygren A Douglas-Jones GC Smith NM Martin M O'Connor AR Clarke 2009 Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin Cancer Res 69 3850 3855 19383921 10.1158/0008-5472.CAN-08-2388 1:CAS:528:DC%2BD1MXltFOksLw%3D
7. EA Comen M Robson 2010 Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer Oncology (Williston Park) 24 55 62
8. PC Fong DS Boss TA Yap A Tutt P Wu M Mergui-Roelvink P Mortimer H Swaisland A Lau MJ O'Connor A Ashworth J Carmichael SB Kaye JH Schellens JS de Bono 2009 Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N Engl J Med 361 123 134 19553641 10.1056/NEJMoa0900212 1:CAS:528:DC%2BD1MXosVKrtrw%3D
9. K Nosho H Yamamoto M Mikami H Taniguchi T Takahashi Y Adachi A Imamura K Imai Y Shinomura 2006 Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis Eur J Cancer 42 2374 2381 16809031 10.1016/j.ejca.2006.01.061 1:CAS:528:DC%2BD28Xptlykt7g%3D (Pubitemid 44307612)
10. B Csete Z Lengyel Z Kadar Z Battyani 2009 Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor Pathol Oncol Res 15 47 53 18752052 10.1007/s12253-008-9086-0 1:CAS:528:DC%2BD1MXktlyqsbk%3D
11. B Gorski C Cybulski T Huzarski T Byrski J Gronwald A Jakubowska M Stawicka S Gozdecka-Grodecka M Szwiec K Urbanski J Mitus E Marczyk J Dziuba P Wandzel D Surdyka O Haus H Janiszewska T Debniak A Toloczko-Grabarek K Medrek B Masojc M Mierzejewski E Kowalska SA Narod J Lubinski 2005 Breast cancer predisposing alleles in Poland Breast Cancer Res Treat 92 19 24 15980987 10.1007/s10549-005-1409-1 1:STN:280:DC%2BD2MzivVWqtQ%3D%3D (Pubitemid 40875074)
12. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 1757079 10.1111/j.1365-2559.1991.tb00229.x 1:STN:280:DyaK38%2FpvVSltw%3D%3D
13. JL Haybittle RW Blamey CW Elston J Johnson PJ Doyle FC Campbell RI Nicholson K Griffiths 1982 A prognostic index in primary breast cancer Br J Cancer 45 361 366 7073932 10.1038/bjc.1982.62 1:STN:280:DyaL387ot1KmsQ%3D%3D (Pubitemid 12122304)
14. S Detre G Saclani Jotti M Dowsett 1995 A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas J Clin Pathol 48 876 878 7490328 10.1136/jcp.48.9.876 1:STN:280:DyaK28%2Fps1arsQ%3D%3D
15. AC Wolff ME Hammond JN Schwartz KL Hagerty DC Allred RJ Cote M Dowsett PL Fitzgibbons WM Hanna A Langer LM McShane S Paik MD Pegram EA Perez MF Press A Rhodes C Sturgeon SE Taube R Tubbs GH Vance M van de Vijver TM Wheeler DF Hayes 2007 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Arch Pathol Lab Med 131 18 43 19548375 1:CAS:528: DC%2BD2sXhsVOmu74%3D (Pubitemid 46174133)
16. ME Hammond DF Hayes M Dowsett DC Allred KL Hagerty S Badve PL Fitzgibbons G Francis NS Goldstein M Hayes DG Hicks S Lester R Love PB Mangu L McShane K Miller CK Osborne S Paik J Perlmutter A Rhodes H Sasano JN Schwartz FC Sweep S Taube EE Torlakovic P Valenstein G Viale D Visscher T Wheeler RB Williams JL Wittliff AC Wolff 2010 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer Arch Pathol Lab Med 134 E1 E16
17. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D (Pubitemid 39100473)
18. MC Cheang D Voduc C Bajdik S Leung S McKinney SK Chia CM Perou TO Nielsen 2008 Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 1368 1376 18316557 10.1158/1078-0432.CCR-07-1658 1:CAS:528:DC%2BD1cXislSrs7o%3D (Pubitemid 351413917)
19. Z Fu C Fenselau 2005 Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance J Proteome Res 4 1583 1591 16212410 10.1021/pr0501158 1:CAS:528:DC%2BD2MXhtVWmtrfF (Pubitemid 41464784)
20. N McCabe MA Cerone T Ohishi H Seimiya CJ Lord A Ashworth 2009 Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer Oncogene 28 1465 1470 19182824 10.1038/onc.2008.483 1:CAS:528:DC%2BD1MXht1ehs7c%3D
21. I Bieche G de Murcia R Lidereau 1996 Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer Clin Cancer Res 2 1163 1167 9816283 1:STN:280:DyaK1M%2FjsFWgsw%3D%3D (Pubitemid 26238447)
22. NC Turner JS Reis-Filho AM Russell RJ Springall K Ryder D Steele K Savage CE Gillett FC Schmitt A Ashworth AN Tutt 2007 BRCA1 dysfunction in sporadic basal-like breast cancer Oncogene 26 2126 2132 17016441 10.1038/sj.onc.1210014 1:CAS:528:DC%2BD2sXjsFSiu7c%3D (Pubitemid 46514749)
23. D Inbar-Rozensal A Castiel L Visochek D Castel F Dantzer S Izraeli M Cohen-Armon 2009 A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors Breast Cancer Res 11 R78 19891779 10.1186/bcr2445